These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 11297592)

  • 1. Combined treatment with corticosteroids and moclobemide favors normalization of hypothalamo-pituitary-adrenal axis dysregulation in relapsing-remitting multiple sclerosis: a randomized, double blind trial.
    Then Bergh F; Kümpfel T; Grasser A; Rupprecht R; Holsboer F; Trenkwalder C
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1610-5. PubMed ID: 11297592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulation of the hypothalamo-pituitary-adrenal axis is related to the clinical course of MS.
    Then Bergh F; Kümpfel T; Trenkwalder C; Rupprecht R; Holsboer F
    Neurology; 1999 Sep; 53(4):772-7. PubMed ID: 10489039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients.
    Binder EB; Künzel HE; Nickel T; Kern N; Pfennig A; Majer M; Uhr M; Ising M; Holsboer F
    Psychoneuroendocrinology; 2009 Jan; 34(1):99-109. PubMed ID: 18829172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive impairment correlates with hypothalamo-pituitary-adrenal axis dysregulation in multiple sclerosis.
    Heesen C; Gold SM; Raji A; Wiedemann K; Schulz KH
    Psychoneuroendocrinology; 2002 May; 27(4):505-17. PubMed ID: 11912002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of hypothalamic-pituitary-adrenal system response to a combined dexamethasone-CRH test in multiple sclerosis.
    Grasser A; Möller A; Backmund H; Yassouridis A; Holsboer F
    Exp Clin Endocrinol Diabetes; 1996; 104(1):31-7. PubMed ID: 8750568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time matters - acute stress response and glucocorticoid sensitivity in early multiple sclerosis.
    Kern S; Rohleder N; Eisenhofer G; Lange J; Ziemssen T
    Brain Behav Immun; 2014 Oct; 41():82-9. PubMed ID: 24880115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive dysregulation of autonomic and HPA axis functions in HIV-1 clade C infection in South India.
    Chittiprol S; Kumar AM; Satishchandra P; Taranath Shetty K; Bhimasena Rao RS; Subbakrishna DK; Philip M; Satish KS; Ravi Kumar H; Kumar M
    Psychoneuroendocrinology; 2008 Jan; 33(1):30-40. PubMed ID: 17993249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of Hatha yoga as an add-on treatment in major depression on hypothalamic-pituitary-adrenal-axis activity: a randomized trial.
    Sarubin N; Nothdurfter C; Schüle C; Lieb M; Uhr M; Born C; Zimmermannc R; Bühner M; Konopka K; Rupprecht R; Baghai TC
    J Psychiatr Res; 2014 Jun; 53():76-83. PubMed ID: 24655586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypothalamo-pituitary-adrenal axis activity evolves differentially in untreated versus treated multiple sclerosis.
    Kümpfel T; Schwan M; Weber F; Holsboer F; Trenkwalder C; Then Bergh F
    Psychoneuroendocrinology; 2014 Jul; 45():87-95. PubMed ID: 24845180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial.
    Ravnborg M; Sørensen PS; Andersson M; Celius EG; Jongen PJ; Elovaara I; Bartholomé E; Constantinescu CS; Beer K; Garde E; Sperling B
    Lancet Neurol; 2010 Jul; 9(7):672-80. PubMed ID: 20542736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothalamo-pituitary-adrenal axis activity predicts disease progression in multiple sclerosis.
    Gold SM; Raji A; Huitinga I; Wiedemann K; Schulz KH; Heesen C
    J Neuroimmunol; 2005 Aug; 165(1-2):186-91. PubMed ID: 15935481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circadian cortisol, depressive symptoms and neurological impairment in early multiple sclerosis.
    Kern S; Schultheiss T; Schneider H; Schrempf W; Reichmann H; Ziemssen T
    Psychoneuroendocrinology; 2011 Nov; 36(10):1505-12. PubMed ID: 21621332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simvastatin treatment in patients with relapsing-remitting multiple sclerosis receiving interferon beta 1a: a double-blind randomized controlled trial.
    Togha M; Karvigh SA; Nabavi M; Moghadam NB; Harirchian MH; Sahraian MA; Enzevaei A; Nourian A; Ghanaati H; Firouznia K; Jannati A; Shekiba M
    Mult Scler; 2010 Jul; 16(7):848-54. PubMed ID: 20488825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
    Wichniak A; Brunner H; Ising M; Pedrosa Gil F; Holsboer F; Friess E
    Psychoneuroendocrinology; 2004 Oct; 29(9):1101-8. PubMed ID: 15219633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired hypothalamic-pituitary-adrenal axis activity in patients with multiple sclerosis.
    Ysrraelit MC; Gaitán MI; Lopez AS; Correale J
    Neurology; 2008 Dec; 71(24):1948-54. PubMed ID: 19064876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial.
    Sorensen PS; Mellgren SI; Svenningsson A; Elovaara I; Frederiksen JL; Beiske AG; Myhr KM; Søgaard LV; Olsen IC; Sandberg-Wollheim M
    Lancet Neurol; 2009 Jun; 8(6):519-29. PubMed ID: 19409854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypothalamic-pituitary-adrenocortical axis dysregulation in patients with major depression is influenced by the insertion/deletion polymorphism in the angiotensin I-converting enzyme gene.
    Baghai TC; Schule C; Zwanzger P; Minov C; Zill P; Ella R; Eser D; Oezer S; Bondy B; Rupprecht R
    Neurosci Lett; 2002 Aug; 328(3):299-303. PubMed ID: 12147330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol--a double-blind multicenter trial.
    Künzel HE; Ackl N; Hatzinger M; Held K; Holsboer-Trachsler E; Ising M; Kaschka W; Kasper S; Konstantinidis A; Sonntag A; Uhr M; Yassouridis A; Holsboer F; Steiger A
    J Psychiatr Res; 2009 Apr; 43(7):702-10. PubMed ID: 19038406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatigue and regulation of the hypothalamo-pituitary-adrenal axis in multiple sclerosis.
    Gottschalk M; Kümpfel T; Flachenecker P; Uhr M; Trenkwalder C; Holsboer F; Weber F
    Arch Neurol; 2005 Feb; 62(2):277-80. PubMed ID: 15710856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological and nonpharmacological factors influencing hypothalamic-pituitary-adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex-CRH test.
    Künzel HE; Binder EB; Nickel T; Ising M; Fuchs B; Majer M; Pfennig A; Ernst G; Kern N; Schmid DA; Uhr M; Holsboer F; Modell S
    Neuropsychopharmacology; 2003 Dec; 28(12):2169-78. PubMed ID: 12931142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.